You are here

Criminal Litigation & Procedure

Displaying 21 - 30 of 226, sorted by most recent
Contains
Contains
Format: 2024
Greater than or equal to
Robert L. DuPont, Jason A. Cantone
December 3, 2020

Dr. Robert DuPont, an expert in drug-abuse prevention and treatment for fifty years, served as the first director of the National Institute for Drug Abuse (NIDA) and as the second White House Drug Chief under Presidents Nixon and Ford. Dr.

Louis F. Ortenzio Jr., Hanna Umanskiy Ortiz
December 3, 2020

Lou Ortenzio, a former physician who lost his career and his marriage in his struggle with opioids, shares his experience assisting others who seek to recover from substance use disorder in his home town of Clarksburg, West Virginia.

Joseph LaFratta, Mary Page Kelley, Jason A. Cantone
December 3, 2020

Chief Magistrate Judge M. Page Kelley (D. Mass.) and Deputy Chief Probation Officer Joseph LaFratta (D. Mass.) discuss the structure, commitment required, and lessons learned from their court’s experience with a successful drug treatment court program. 

 

Irene M. Keeley
December 3, 2020

In concluding remarks, Judge Irene Keeley (N.D. W.

Irene M. Keeley
December 3, 2020

Judge Irene M. Keeley (N.D. W. Va.) introduces this series, designed to provide judges with a basic understanding of opioid use and its effect on the federal courts, and outlines the objective: to equip judges with a series of takeaways they can readily apply in their respective courts.

Robert Redfield, Hanna Umanskiy Ortiz
December 3, 2020

Dr. Robert Redfield, director of the Centers for Disease Control and Prevention (CDC), identifies drug use disorder as the public health crisis of our time.

Christopher Jones, Hanna Umanskiy Ortiz
December 3, 2020

Dr. Christopher Jones, U.S. Public Health Service and Centers for Disease Control and Prevention (CDC), reviews current options (to include methadone, buprenorphine and naltrexone) in Medication-Assisted Treatment (MAT) for those with an opioid use disorder.

Wilson Compton, Jason A. Cantone
December 3, 2020

Dr. Wilson Compton, deputy director of the National Institute on Drug Abuse (NIDA), explains what judges need to know about the biology, neurobiology, and chemistry of opioid use disorder.

April 27, 2020

This package of materials was transmitted to Congress on April 27, 2020, concerning amendments to the Federal Rules of Practice and Procedure to become effective on December 1, 2020.

Amendments to the Federal Rules of Practice and Procedure are as follows:

Pages

Subscribe to Criminal Litigation & Procedure